Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incretin-based therapies: a clinical need filled by unique metabolic effects.

× No keyword cloud information.

5 in total

1. Tripeptidyl peptidase II promotes fat formation in a conserved fashion.

Authors: Renée M McKay; James P McKay; Jae Myoung Suh; Leon Avery; Jonathan M Graff
Journal: EMBO Rep Date: 2007-10-12 Impact factor: 8.807

Review 2. Diabetes is predominantly an intestinal disease.

Authors: Debmalya Sanyal
Journal: Indian J Endocrinol Metab Date: 2013-10

3. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor.

Authors: Nicolai M Doliba; Qin Liu; Changhong Li; Pan Chen; Chengyang Liu; Ali Naji; Franz M Matschinsky
Journal: Mol Metab Date: 2017-08-04 Impact factor: 7.422

Review 4. What's next after metformin? focus on sulphonylurea: add-on or combination therapy.

Authors: Phei C Lim; Chee P Chong
Journal: Pharm Pract (Granada) Date: 2015-06-15

Review 5. Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes.

Authors: Katherine V Mann; Philip Raskin
Journal: Diabetes Metab Syndr Obes Date: 2014-06-24 Impact factor: 3.168

5 in total